We are live on ! Find out more
MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

15 hedge funds and large institutions have $607K invested in Stealth BioTherapeutics Corp. ADS in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

7% more funds holding

Funds holding: 14 → 15 (+1)

39% less capital invested

Capital invested by funds: $987K → $607K (-$380K)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GSC
Ground Swell Capital
South Carolina
+$19.7K
2
Citadel Advisors
Citadel Advisors
Florida
+$16.9K
3
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$12.9K
4
Millennium Management
Millennium Management
New York
+$4.38K
5
Osaic Holdings
Osaic Holdings
Arizona
+$2.41K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$26K
2
SBL
Sargent Bickham Lagudis
Colorado
-$20K
3
Renaissance Technologies
Renaissance Technologies
New York
-$10.2K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$1.24K
5
Morgan Stanley
Morgan Stanley
New York
-$1.04K
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$397K – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$48K -$10.2K -9,827 -15%
BFM
3
Boothbay Fund Management
New York
$40K – – –
Millennium Management
4
Millennium Management
New York
$33K +$4.38K +4,198 +12%
Two Sigma Advisers
5
Two Sigma Advisers
New York
$21K -$209 -200 -0.8%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$19K -$1.24K -1,185 -5%
GSC
7
Ground Swell Capital
South Carolina
$16K +$19.7K +18,927 New
Citadel Advisors
8
Citadel Advisors
Florida
$13K +$16.9K +16,213 New
Envestnet Asset Management
9
Envestnet Asset Management
Illinois
$10K +$12.9K +12,417 New
Morgan Stanley
10
Morgan Stanley
New York
$4K -$1.04K -1,000 -17%
Osaic Holdings
11
Osaic Holdings
Arizona
$4K +$2.41K +2,314 +84%
AA
12
AlphaMark Advisors
Kentucky
$2K – – –
BBHC
13
Brown Brothers Harriman & Co
New York
$145 – – –
HF
14
HRT Financial
New York
– -$26K -19,835 Closed
SBL
15
Sargent Bickham Lagudis
Colorado
– -$20K -14,714 Closed
JP Morgan Chase
16
JP Morgan Chase
New York
– +$210 +201 New

MITO Hedge Fund Activity: Q4 2021 in Review

15 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q4 2021, worth a combined $607K — down 39% from $987K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new MITO positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Ground Swell Capital, opening a new position worth an estimated $19.7K. The largest seller was HRT Financial, exiting entirely with an estimated $26K sold.

  • 15 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q4 2021, up from 14 in Q3 2021.
  • Funds reported $607K of Stealth BioTherapeutics Corp. ADS stock for Q4 2021, down 39% quarter-over-quarter.
  • 4 funds opened new Stealth BioTherapeutics Corp. ADS positions in Q4 2021 and 3 closed out, a net change of +1 holder.
  • The largest Stealth BioTherapeutics Corp. ADS buyer in Q4 2021 was Ground Swell Capital, an estimated $19.7K added.
  • The largest Stealth BioTherapeutics Corp. ADS seller in Q4 2021 was HRT Financial, an estimated $26K sold.

Based on aggregated 13F filings for Q4 2021.